A failure of metabolic processes in red cells is believed to initiate changes leading to their sequestration and destruction in the reticuloendothelial system, principally in the liver and spleen (1, 2) . Since red cells derive virtually all of their energy from glucose, it appears that the decline in activity of certain glycolytic enzymes during normal red cell aging may determine the life span of the cell (3) (4) (5) . The rate of "senescence" is somewhat increased in red cells of subjects whose oxidative shunt (pentose phosphate pathway) is impaired by a deficiency of the enzyme, glucose-6-phosphate dehydrogenase (G6PD) (6, 7) , and is greatly increased in red cells defective in the main glycolytic pathway, as by a deficiency of pyruvate kinase (8) . Applying stress to such defective red cells, e.g., by administering a potentially oxidant compound to G6PD-deficient subjects, markedly accelerates the rate of cell damage and destruction (9, 10) .
The way in which defective glycolysis causes the red cell to be recognized, trapped, and destroyed by reticuloendothelial cells is not known, although it is reasonable to assume that ultimately the red cell membrane must be altered, since it is the surface of the cell that comes in contact with the erythroclastic cells.
Subsequent to the work of others (11) (12) (13) (14) indicating that sulfhydryl compounds are involved in certain hemolytic mechanisms, evidence was presented in a preceding paper (15) that the shape and viability of red cells in vitro depend upon the maintenance of membrane sulfhydryl groups. When these groups are blocked by specific inhibitors, the red cells undergo the following sequence of events: 1) cation gradients across the cell membrane are disrupted, with a cellular loss of K+ and a gain of Na+; 2) the resulting unopposed * This work was supported by Grant RG3507 (C8) from the National Institutes of Health, Bethesda, Md. oncotic pressure of hemoglobin and other intracellular macromolecules causes an influx of water leading to cellular swelling and spherocytosis; and 3) ultimately the cell membrane becomes distended, permitting the leakage of hemoglobin (i.e. hemolysis). It was suggested that this sequence of events, observed after the addition of specific sulfhydryl inhibitors, may be likened to the sequence of cellular injury in various hemolytic processes. Accordingly, studies were made, and are presented here, of the behavior of sulfhydrylinhibited red cells in man and in rats, the findings in vivo being correlated with the physical and biochemical alterations produced. A preliminary report has been published (16) .
METHODS
As in the previous studies (15) the sulfhydryl inhibitors employed were p-mercuribenzoate (PMB),' which does not penetrate the intact red cell membrane (15, 17) , and N-ethylmaleimide (NEM),2 which rapidly permeates the normal red cell (15, 18) . The inhibitors were dissolved in physiologic saline and were rendered sterile by Seitz filtration shortly before use. Although quite different chemically, both compounds react rather specifically with sulfhydryl groups, and both cause very similar damage to the red cell membrane (15) . Accordingly, their effects will be attributed throughout this paper to specific reactions with sulfhydryl groups and will be referred to as involving sulfhydryl "inhibition" or "blockade." It should be recognized that this inference is based upon circumstantial evidence, as is the case with other inhibitors.
Techniques applicable to studies in man. Unless otherwise stated, 25 ml of blood from hematologically normal subjects was collected with sterile precautions in acidcitrate-dextrose (ACD) solution, and the cells labeled with Cr`1 by incubation for 30 minutes at room tempera- (19, 20) and for hemoglobin by the benzidine method (21) . At less frequent intervals blood was also collected in oxalate for determinations of osmotic fragility. The fragility of the circulating Cr51-labeled cells was followed at various intervals after injection by comparing the radioactivity and hemoglobin concentration of the spun supernatants from blood added to graded hypotonic salt solutions [the previously described differential osmotic fragility technique (22, 23) ].
Sites of cell sequestration were determined by body- 3 Abbott Laboratories, North Chicago, Ill.
surface monitoring over spleen, liver, and precordium as previously described (24) . In preliminary work the possible effects of NEM and PMB on the uptake and elution of Cr51 by red cells were studied in vitro. Neither agent appreciably affected the cellular uptake of Cr51 as Na2Cr'O4, whether the inhibitor was added to the cell suspension before or after the Cr'. The elution of Cr51 from red cells exposed to these inhibitors was observed over a 48-hour period of sterile incubation in buffered saline and in serunm Although elution from inhibited cells somewhat exceeded that of the control cells in this period, this was largely accounted for by their increased autohemolysis. When the ratio of intracellular:extracellular Cr55 .as corrected for autohemolysis, the rates of elution of Cr' from control cells and from sulfhydryl-inhibited cells were comparable.
Red cell dimensions and concentrations were measured by standard techniques (21) . The consumption of glucose by red cells was measured by the Somogyi-Nelson technique (25) ; their production of lactate was measured by the method of Barker and Summerson (26) . Red cell glutathione (GSH) levels were determined by the nitroprusside method of Grunert and Phillips (27) as modified by Beutler (28) and by the "alloxan 305" method (29) .
As noted in the first part of this study (15) urement of thiols in the presence of PMB, the "alloxan 305" method was used.
Techniques applicable to studies in rats. The experiments were made on large (400 to 500 g) males from a Bartonella-free strain (Charles River C.D.) of SpragueDawley rat. Small volumes (5 to 10 ml) of rat blood in ACD were labeled with Na2Cr5104 as described above.
The labeled cells were incubated with the appropriate sulfhydryl inhibitor for 1 hour, washed, and injected by tail vein into each of several other recipient animals. The usual dose of injected cells was 1.0 ml of a 25 per cent cell suspension containing 1 to 3 Acc of Cr51.
At various intervals after injection the animals were sacrificed; cardiac blood, spleen, liver, kidneys, lungs, and femurs were removed and counted as described previously (30) . Intact red cells were obtained from the spleens of these animals by gentle homogenization of that organ in a loosely fitting Potter-Elvejhem homogenizer. This homogenate, containing released, radioactive, splenic red cells, was added to hypotonic salt solutions and the osmotic fragility of the labeled cells determined as described above.
Phagocytosis studies. The phagocytosis of sulfhydrylinhibited red cells was studied by means of the test-tube technique outlined by Packer and colleagues (31) and also by a modified Rebuck and Crowley window technique (32) as follows. Sulfhydryl-inhibited human red cells in fresh autologous serum were added to the forearm of the donor 3 hours after sterile inflammation had been produced by scarification. At various intervals thereafter the cover glasses were removed and examined for erythrophagocytosis. Studies of phagocytosis in rats were made by examining splenic imprints at various intervals after intravenous injection of sulfhydryl-inhibited cells.
RESULTS
Studies of NEM-treated cells in man. Autogenous, Cr51-labeled red cells that had been treated with small, nonhemolyzing doses of NEM were rapidly removed from the normal circulation, as 1 demonstrates that the cells so treated were selectively trapped in the spleen. This sequestration was not followed by hemoglobinemia. However, plasma bilirubin levels rose from a baseline level of 0.4 to 1.4 mg per 100 ml at 2 hours, and 1.6 mg per 100 ml at 4 hours after injection of 200 ml of a 50 per cent suspension of NEMtreated cells. There was no effect on either circulating white cell levels or body temperature of the injected subjects.
The special role of the spleen in trapping red cells so treated with NEM was further studied on two occasions in an otherwise normal individual who had been splenectomized several months earlier because of a traumatic splenic rupture. As shown in the right portion of Figure 1 , NEMtreated cells survived over 30 times longer in the splenectomized patient (T50 = 11 hours) than in normal individuals. During this slow clearance of treated cells no increase in their osmotic fragility was observed in vivo.
The effects of various doses of NEM on red cell GSH and on red cell survival are compared in Table I . Amounts of NEM sufficient to block as much as 90 per cent of cellular GSH had no effect on cell survival. At doses just sufficient to block all GSH, red cell survival was impaired, with a slow selective sequestration of labeled cells by the spleen (Figure 2 , left portion). Cells so treated were of normal size, shape, and fragility. In contrast, much larger doses of NEM, in calculated excess of that necessary to block all the sulfhydryl groups of cellular hemoglobin as well as of GSH (15) , caused some spherocytosis, increased osmotic fragility, and slight autohemolysis. Red cells treated with these large doses were rapidly removed from the circulation with seques- tration in the liver as well as in the spleen ( Figure  2 , right portion). This rapid sequestration was also attended by hyperbilirubinemia, beginning 1 hour after injection, but not by hemoglobinemia.
These observations, summarized in Table I (15) . These cells, although metabolically active, when reinjected were rapidly removed from the circulation, being trapped mainly in the spleen (Figure 3) . The osmotic fragility of these labeled circulating cells remained normal during their brief period of survival in vivo. Sequestration was followed by a bilirubin peak in the plasma but not by hemoglobinemia. These cells, therefore, despite their normal glycolytic activity and normal GSH levels, behaved in a fashion analogous to that of red cells treated with sufficient NEM to block all GSH. As with NEM, doses of PMB great enough to cause uniform spherocytosis and slight autohemolysis caused more rapid cell disappearance accompanied by marked hepatic as well as splenic sequestration. Doses less than that cited in Figure  3 caused lesser rates of cell sequestration. There was no clear threshold dose as with NEM. Thus a dose of 1 ,umole PMB per ml red cells caused the rapid destruction of a minor population of cells (about 30 to 40 per cent of those injected), while the remainder survived normally.
That the survival of Cr5' in sulfhydryl-inhibited red cells was not spuriously shortened in vivo as the result of a possible increased elution of the isotope is indicated by the following: 1) radioactivity accumulated in specific organs rather than appearing in the plasma, other circulating red cells, or urine, as would be the case with freed Cr51 (24) ; 2) in the absence of the spleen the survival of Cr51 in inhibited red cells was markedly prolonged; 3) the disappearance of Cr51-labeled cells from the blood stream was followed by hyperbilirubinemia and, with the bigger doses of inhibitor, by hemoglobinemia; 4) in animals (see below) the injection of sulfhydryl-inhibited red cells was followed by splenic engorgement with red cells and, after a delay, by evidence of erythrophagocytosis.
Studies of phagocytosis of sulfhydryl-inhibited red cells in man. Although autogenous A-positive red cells exposed for short periods in vitro to complement-fixing anti-A underwent erythrophagocytosis when placed subsequently in skin-window preparations, this phenomenon was not observed when sulfhydryl-inhibited red cells were employed. Similarly, phagocytosis of inhibited cells by autologous granulocytes in the presence of fresh serum was not demonstrable in the test tube, whereas in parallel preparations anti-A did induce erythrophagocytosis of A-positive red cells.
Studies of sulfhydryl-inhibited red cells in rats. The behavior of sulfhydryl-inhibited cells in the rat circulation was similar to that found in man. Both NEM-treated cells (Figure 4 ) and PMBtreated cells disappeared from the circulation within 4 to 6 hours after injection. With the doses employed, total spleen uptake was 2 to 5 times that of the liver and splenic uptake was 30 to 80 times that of the liver on a gram-for-gram basis. In addition. as in man, a marked prolonga-I tion of survival of sulfhydryl-inhibited cells was found in splenectomized rats, despite enhanced hepatic uptake in these animals.
As in man, the trapping of sulfhydryl-inhibited rat red cells by splenic tissue was not necessarily preceded by their sphering, as measured by the osmotic fragility of these circulating, labeled cells.
The gentle homogenization of rat spleens at varying intervals after cell injection caused the release of intact labeled cells from this organ and allowed their fragility to be measured at such times. Figure 5 illustrates the radioactive osmotic fragility curves so obtained. It is noted that the initial (16-minute) fragility of sequestered cells was nearly normal. After 1 hour, at a time when 45 per cent of injected cells had already been removed from the circulation, an osmotically fragile population appeared. Still greater increases in fragility were found in those few intact cells residing for more prolonged periods in the spleen ( Figure 5 ).
Evidence (35) . It should be noted that, with both sulfhydryl-inhibited and antibody-coated cells (36) , the pattern of sequestration and thus the specificity of the spleen are influenced by quantitative factors.
The means by which the spleen so specifically recognizes altered cells remains enigmatic. The ability of the spleen to act as a "filter" for abnormally shaped cells has been well documented in conditions that occur naturally, such as hereditary spherocytosis (37) and, possibly, hereditary elliptocytosis (38) . Similarly, experimentally produced spherocytes (39) have been effectively filtered from the circulation by the spleen. The cells in the present studies, however, appeared of normal shape and size upon microscopic inspection, and did not show increased osmotic fragility either prior to or during their circulation and sequestration. Indeed, it was found that sulfhydrylinhibited red cells trapped in rat spleens were of nearly normal osmotic fragility for at least 16 minutes after trapping. Only after more prolonged sequestration was there an increase in osmotic fragility of spleen-sequestered red cells, whereas no such change occurred during incubation of these cells for the same time in plasma at 370 C in vitro. Thus, we found that spheroidicity was imparted by exposure of these cells to the spleen. With sulfhydryl-inhibited red cells, as is probably the case with antibody-coated cells (40) (41) (42) , sequestration is not preceded by a spheroidal change in the cells but, rather, induces it.
It has been proposed that the spleen recognizes globulin-coated cells by a change in their surface characteristics, for instance, by their propensity to agglutinate in rouleaux-forming media (43) . In a similar fashion, the trapping of sulfhydrylinhibited cells may be secondary to physicochemical alteration of the cell membrane itself. In support of this contention is the finding that, at the low doses used in these experiments, PMB does not penetrate the intact red cell membrane (15); presumably, therefore, it induces rapid splenic sequestration by direct injury to this membrane only. NEM, on the other hand, was shown to enter the red cell freely, thereby inhibiting glycolysis and binding intracellular GSH. However, evidence that this sulfhydryl inhibitor also owed its in vitro hemolytic activity to direct membrane injury was presented (15) .
In order to assess the possible part, if any, that the inhibition of glycolysis, per se, might play in the destruction of NEM-treated cells in vivo, the behavior of fluoride-and arsenate-treated red cells was studied in man. It was found that cells treated with arsenate disappeared slowly from the human circulation over 24 hours, and were trapped primarily in the liver, results confirming the data of Harris, McAlister and Prankerd (39) . Cells treated with fluoride for 6 hours in vitro, under conditions shown to reduce cellular ATP to 30 per cent of original levels (44), disappeared as two separate populations. Approximately half the treated cells were removed from the human circulation with a half-clearance of 24 hours, sequestration being equal in liver and spleen, while the remainder survived normally. The cells of this latter population presumably were able to expel fluoride ion in exchange for chloride prior to the onset of irreversible cellular damage. Despite such prolonged metabolic inhibition in both the arsenate-and fluoride-treated cells, little tendency for these cells to accumulate in the spleen was noted, in contrast to observations with NEMtreated cells. Thus it is clear that cessation of glycolysis per se leads to a delayed injury to the cell in which several hours are required for minimal impairment of viability, in contrast to sulfhydryl-inhibited cells, in which irreversible injury occurs within a few minutes. These observations in vivo support the earlier conclusion (15) that NEM and PMB do not act merely to block regeneration of high-energy phosphate compounds such as ATP. The delayed and relatively mild effects of fluoride and arsenate upon red cell survival also emphasize the specificity of sulfhydryl inhibition in the mechanism of splenic sequestration.
Unlike antibody-coated cells, sulfhydryl-deficient red cells do not agglutinate in Coombs sera or in polyvinylpyrrolidone. Furthermore, sulfhydryl-inhibited cells are not abnormally prone to form rouleaux as measured microscopically or by sedimentation rates. However, a change in electrostatic potential of the sulfhydryl-deficient red cell membrane might underlie its propensity to be trapped by the spleen. In this regard, it was suggested by the early studies of Robinson (45) that differences in the affinity of the spleen for colloidal particles might relate to their electrical properties. Such a hypothesis remains for study. In addition, a possible relation of membrane sulfhydryl activity to cell "stickiness" was shown in the studies of Philipson and Choppin, who blocked with sulfhydryl inhibitors the attachment of viruses to red cells (46) and to tissue culture cells (47) . In addition, it has been shown that modification of leukocytes by PMB inhibits their "adhesiveness" to siliconized glass beads (48) . However, the relevance of these in vitro alterations of cellular adhesiveness to the mechanism of red cell trapping by the spleen in the present studies remains conj ectural.
Enhanced A second association was that the propensity of altered red cells to be sequestered in the liver, and to undergo autohemolysis upon prolonged incubation, was coincident with the tendency of these cells to take up Na+ and to manifest spherocytosis and an increase in osmotic fragility. Again, it is probable that the cation changes were correlative rather than causative. Finally, the close association of membrane sulfhydryl inhibition and disturbed cation control with diminished cell viability should be emphasized, as should the lack of association of intracellular sulfhydryl activity and glycolysis with in vivo survival.
The present studies, in conjunction with the earlier findings of Beutler and colleagues (12, 28) , suggest that, in the course of poisoning by oxidant drugs such as phenylhydrazine and the antimalarials, the eventual product of the intracellular oxidation that critically affects red cell survival is the destruction of membrane sulfhydryl groups. Other hemolytic agents, such as mercury and possibly fava beans, as well as certain antibodies, may act by directly affecting these groups. When injury is relatively mild, splenic sequestration would predominate. When injury is relatively severe, hepatic sequestration and intravascular hemolysis would ensue.
The relevance of these studies to normal red cell senescence is more difficult to evaluate. Although definitive studies of sulfhydryl activity of senescent red cells have not been reported, the expectation that such activity would be diminished, equally with the decreased concentration of numerous enzymes and glycolytic intermediates in aged cells, seems reasonable. The decreased activity of GSH in adult red cells when compared with reticulocytes (49) fits this conjecture. It is suggested that diminished sulfhydryl activity in senescent red cell membranes might lead to the sequestration and destruction of these cells. The finding that reduced GSH also protects hemoglobin in vitro from auto-oxidative breakdown (50, 51) leads one to speculate as follows: 1) a failure of glycolytic activity in senescent cells leads to diminished intracellular sulfhydryl levels and an increase in hemoglobin oxidized; 2) this leads to diminished membrane sulfhydryl activity and thus to cell sequestration and destruction. The circu-lation is thereby freed of cells containing inefficient heme protein through the common intermediate of diminished cellular sulfhydryl concentrations.
SUMMARY
Red cells of human or rat exposed in vitro to sublytic amounts of the sulfhydryl inhibitors Nethylmaleimide (NEM) and p-mercuribenzoate (PMB) are nonviable in vivo. Loss of viability is related to the inhibition of membrane sulfhydryl groups but is unrelated per se to intracellular sulfhydryl levels or to the over-all rate of cellular glycolysis. An association, however, does exist between the ability of these cells to maintain cation gradients in vitro and their ability to survive in vivo.
Red cells treated with small doses of sulfhydryl inhibitor were of normal appearance and fragility and slowly lost K+; such cells on reinjection were trapped by the spleen with remarkable selectivity. Sequestration does not appear to depend upon changes in red cell shape, increased agglutinability, or erythrophagocytosis. After their sequestration in the spleen these red cells showed a progressive increase in osmotic fragility. Larger doses of inhibitor caused Na+ and water ingress, spherocytosis, and a more rapid hepatic, as well as splenic, sequestration.
Since inhibition of high-energy phosphate metabolism in red cells by arsenate caused a delayed, slow destruction of red cells in vivo, and since cessation of anaerobic glycolysis and K+ depletion in red cells by exposure for several hours to fluoride had comparatively little effect upon their subsequent survival, it is concluded that membrane sulfhydryl groups are uniquely important to cell viability.
It is suggested that a loss of membrane sulfhydryl activity may be the decisive hemolytic event common to a number of processes, including the Heinz body anemias and normal cellular aging.
